LENZ – lenz therapeutics, inc. (US:NASDAQ)
Stock Stats
News
LENZ Therapeutics: Was That A Market Overreaction? [Seeking Alpha]
LENZ Therapeutics (NASDAQ:LENZ) had its "buy" rating reaffirmed by analysts at HC Wainwright.
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia
LENZ Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
LENZ Therapeutics to Present at Upcoming Investor Conferences
Form 8-K LENZ Therapeutics, Inc. For: Dec 12
Form 4 LENZ Therapeutics, Inc. For: Nov 17 Filed by: Olsson Shawn
Form 144 LENZ Therapeutics, Inc. Filed by: Olsson Shawn
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.